Client News

Abivax provides 2024 strategic outlook and lays out key milestones over next 12 months

Kizoo leads financing round in Reservoir Neuroscience to restore health to the aging brain

Affluent Medical: Pre-submission dossier for the 510(k) of medical device Kalios filed with FDA for review

Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium

Mainz Biomed Provides Year-End Corporate Review 2023

AiCuris Received 15 Million Euros Milestone Payment from Licensing Partner MSD Following EMA Approval of PREVYMIS® for Prevention of CMV Infection in High-Risk Adult Kidney Transplant Recipients

InflaRx Announces Positive Topline Results from the Multiple Ascending Dose (MAD) Phase I Study with C5aR Inhibitor INF904

Abivax 2024 Financial Communication Calendar

Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia (TRS)

Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenamide